Meningitis Vaccine Injection

Product/Composition Meningitis Vaccine Injection
Form Injection
Strength 10ml
Production Capacity 1 Million Injection/Month
Therapeutic use Anti biotic/ Anti infective/ Anti fungal
Package Insert/Leaflet Available upon request

Meningitis Vaccine Injection is a vaccine designed to protect against infections caused by bacteria that can lead to meningitis, an inflammation of the protective membranes covering the brain and spinal cord. There are different types of meningococcal vaccines targeting various strains (serogroups) of Neisseria meningitidis.

Here are the key details:


1. Composition and Form

  • Contains purified polysaccharides or conjugated polysaccharides from specific meningococcal serogroups (commonly A, C, W, Y, and sometimes B).

  • Supplied as a sterile injectable solution or as a lyophilized powder requiring reconstitution.

  • Administered via intramuscular (IM) injection.


2. Mechanism of Action

  • Stimulates the immune system to produce antibodies against the polysaccharides on the surface of Neisseria meningitidis.

  • Provides active immunity that helps the body recognize and fight the bacteria if exposed.

  • Conjugated vaccines (linked to a protein carrier) produce a stronger, longer-lasting immune response, especially in infants and young children.


3. Indications

  • Routine immunization in children, adolescents, and adults depending on local guidelines.

  • Travelers to regions with high risk of meningococcal disease (e.g., parts of Africa and the Middle East).

  • High-risk individuals: people with asplenia, complement deficiencies, or certain immunodeficiencies.

  • Outbreak control in communities or institutions.


4. Administration

  • Usually given as a single intramuscular injection, with boosters as per local immunization schedules.

  • Typical sites: deltoid muscle in adults, anterolateral thigh in young children.

  • The exact dose, schedule, and need for boosters depend on the type of vaccine and patient’s age.


5. Side Effects

  • Common, mild:

    • Pain, redness, or swelling at the injection site.

    • Low-grade fever.

    • Irritability in infants or fatigue in older children/adults.

  • Less common:

    • Headache, muscle aches, mild gastrointestinal symptoms.

  • Rare:

    • Severe allergic reactions (anaphylaxis).

    • Neurological reactions are extremely rare.


6. Contraindications

  • Severe allergic reaction to a previous dose or vaccine components.

  • Moderate or severe acute illness (vaccination may be deferred).


7. Precautions

  • Inform healthcare provider of any immunodeficiency, chronic illness, or medications that affect immune response.

  • Use with caution in individuals with history of Guillain-Barré syndrome or severe neurological disorders.

  • Ensure observation for 15–30 minutes after injection for rare immediate allergic reactions.


8. Storage

  • Store refrigerated at 2–8°C, protected from light.

  • Do not freeze.

  • Use reconstituted vaccines promptly according to manufacturer instructions.